Zacks Research Predicts Higher Earnings for Northrop Grumman

Northrop Grumman Corporation (NYSE:NOCFree Report) – Equities researchers at Zacks Research lifted their FY2025 earnings per share (EPS) estimates for shares of Northrop Grumman in a research note issued on Tuesday, November 11th. Zacks Research analyst Team now anticipates that the aerospace company will post earnings per share of $26.05 for the year, up from their previous forecast of $25.48. The consensus estimate for Northrop Grumman’s current full-year earnings is $28.05 per share. Zacks Research also issued estimates for Northrop Grumman’s Q1 2026 earnings at $6.04 EPS and FY2026 earnings at $28.55 EPS.

Northrop Grumman (NYSE:NOCGet Free Report) last announced its quarterly earnings data on Tuesday, October 21st. The aerospace company reported $7.67 earnings per share for the quarter, topping analysts’ consensus estimates of $6.43 by $1.24. The firm had revenue of $10.42 billion for the quarter, compared to analyst estimates of $10.68 billion. Northrop Grumman had a return on equity of 25.49% and a net margin of 9.82%.Northrop Grumman’s quarterly revenue was up 4.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $7.00 earnings per share. Northrop Grumman has set its FY 2025 guidance at 25.650-26.050 EPS.

Several other analysts have also recently commented on NOC. Robert W. Baird raised their price objective on shares of Northrop Grumman from $547.00 to $565.00 and gave the company a “neutral” rating in a research note on Wednesday, July 23rd. Susquehanna increased their target price on shares of Northrop Grumman from $650.00 to $690.00 and gave the company a “positive” rating in a report on Wednesday, October 22nd. Morgan Stanley lifted their price target on shares of Northrop Grumman from $625.00 to $720.00 and gave the company an “overweight” rating in a research report on Wednesday, October 15th. Wells Fargo & Company reissued an “overweight” rating on shares of Northrop Grumman in a research note on Tuesday, July 22nd. Finally, Truist Financial raised their price objective on Northrop Grumman from $625.00 to $688.00 and gave the company a “buy” rating in a research note on Wednesday, October 15th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $642.73.

View Our Latest Analysis on Northrop Grumman

Northrop Grumman Price Performance

Shares of NYSE NOC opened at $558.63 on Thursday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.98 and a current ratio of 1.11. Northrop Grumman has a one year low of $426.24 and a one year high of $640.90. The firm has a market capitalization of $79.73 billion, a P/E ratio of 20.09, a PEG ratio of 5.07 and a beta of 0.07. The company’s fifty day moving average is $591.09 and its two-hundred day moving average is $547.02.

Northrop Grumman Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 17th. Investors of record on Tuesday, September 2nd were paid a dividend of $2.31 per share. The ex-dividend date of this dividend was Tuesday, September 2nd. This represents a $9.24 dividend on an annualized basis and a dividend yield of 1.7%. Northrop Grumman’s dividend payout ratio (DPR) is presently 33.24%.

Institutional Investors Weigh In On Northrop Grumman

A number of hedge funds and other institutional investors have recently modified their holdings of NOC. Parvin Asset Management LLC acquired a new position in Northrop Grumman in the 2nd quarter valued at $25,000. IMA Advisory Services Inc. purchased a new stake in shares of Northrop Grumman in the first quarter valued at $27,000. Saudi Central Bank purchased a new stake in shares of Northrop Grumman in the first quarter valued at $28,000. Physician Wealth Advisors Inc. increased its stake in Northrop Grumman by 200.0% in the third quarter. Physician Wealth Advisors Inc. now owns 48 shares of the aerospace company’s stock valued at $29,000 after purchasing an additional 32 shares during the last quarter. Finally, Banque Cantonale Vaudoise purchased a new position in Northrop Grumman during the first quarter worth about $30,000. 83.40% of the stock is currently owned by hedge funds and other institutional investors.

Northrop Grumman Company Profile

(Get Free Report)

Northrop Grumman Corporation operates as an aerospace and defense technology company in the United States, Asia/Pacific, Europe, and internationally. The company’s Aeronautics Systems segment designs, develops, manufactures, integrates, and sustains aircraft systems. This segment also offers unmanned autonomous aircraft systems, including high-altitude long-endurance strategic ISR systems and vertical take-off and landing tactical ISR systems; and strategic long-range strike aircraft, tactical fighter and air dominance aircraft, and airborne battle management and command and control systems.

Featured Articles

Earnings History and Estimates for Northrop Grumman (NYSE:NOC)

Receive News & Ratings for Northrop Grumman Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northrop Grumman and related companies with MarketBeat.com's FREE daily email newsletter.